May 2, 2003 - A retrospective study and results of a phase 3 trial point to new approaches to both short-term cardioversion and long-term maintenance of patients with atrial fibrillation (AF).

Atrial septal defects (ASD) may lead to supraventricular arrhythmias, notably atrial flutter and fibrillation, as a consequence of right atrial volume overload resulting from left-to-right shunting, ...

LISBON, Portugal—Patients presenting to the emergency department (ED) with new, symptomatic A-fib do not necessarily need to undergo immediate cardioversion, as is now common practice, the RACE 7 ...

“Based on our study findings, physicians and patients need to be educated that atrial flutter can be readily cured through catheter ablation, and the procedure may reduce the risk for atrial ...

Early stroke and systemic embolism rates in patients following cardioversion for atrial fibrillation (A-fib) are low and comparable between those receiving warfarin or the novel oral anticoagulant ...

A Food and Drug Administration (FDA) advisory committee has voted 11 to 2 against a recommendation that the agency approve a long-studied antiarrhythmic agent for cardioversion of recent-onset atrial ...

Our heartbeat serves as a vital indicator, which shows how well our heart functions. The heart experiences irregular rhythms ...

A team of Ochsner Health cardiologists recently published an article in the Journal of the American Medical Association (JAMA) Cardiology comparing two treatment strategies for patients with atrial ...